Related Experiment Video
Updated: May 12, 2026
09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Longitudinal white matter changes in Alzheimer's disease: a tractography-based analysis study
Soichiro Kitamura1, Kuniaki Kiuchi, Toshiaki Taoka
1Department of Psychiatry, Nara Medical University, Kashihara, Japan. kitaso@naramed-u.ac.jp
Brain Research
|April 16, 2013
Summary
Alzheimer's disease (AD) progression shows white matter changes. Diffusion tensor imaging (DTI) reveals white matter tract alterations correlating with AD advancement, serving as a potential biomarker.
Area of Science:
- Neuroimaging
- Neurology
- Biomarkers
Background:
- Alzheimer's disease (AD) is characterized by gray matter atrophy and white matter abnormalities.
- Pathological changes in AD worsen with disease progression.
- Understanding white matter tract alterations is crucial for tracking AD progression.
Purpose of the Study:
- To investigate the correlation between white matter tract alterations and Alzheimer's disease progression.
- To assess the utility of diffusion tensor imaging (DTI) parameters in monitoring AD.
- To identify specific white matter tracts affected in AD.
Main Methods:
- Recruited 35 AD patients and 29 controls for baseline and follow-up DTI scans and cognitive assessments.
- Acquired magnetic resonance diffusion tensor imaging (DTI) data.
- Calculated diffusion parameters (FA, ADC, DR, DA) in the uncinate fasciculus (UNC), inferior longitudinal fasciculus (ILF), and inferior occipitofrontal fasciculus (IOFF).
Main Results:
- AD patients showed significant reductions in fractional anisotropy (FA) in the bilateral uncinate fasciculus (UNC) at follow-up.
- A significant increase in radial diffusivity (DR) was observed in the left UNC of AD patients.
- AD patients exhibited significant diffusion parameter abnormalities in UNC, ILF, and IOFF compared to controls.
Conclusions:
- Progressive white matter alterations in AD can be quantified using DTI parameters.
- DTI-derived diffusion parameters show promise as biological markers for monitoring AD.
- These findings highlight the role of white matter integrity in AD pathophysiology.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...